This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Not So Selective Serotonin Reuptake Inhibitors

Stephen M. Stahl

Published: July 15, 1998

Article Abstract
Selective serotonin reuptake inhibitors (SSRIs) got this name from their greater selectivity (10-fold or more) for blocking serotonin reuptake rather than norepinephrine reuptake. They also lack the sodium channel blocking properties of the tricyclic antidepressants, making them safe in overdose. In addition, SSRIs have less affinity for α1-receptors, muscarinic cholinergic receptors, and histamine-1 receptors compared with the tricyclic antidepressants, leading to the greater tolerability profile of SSRIs.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 59

Quick Links: Psychopharmacology

Sign-up to stay
up-to-date today!


Already registered? Sign In

Clinical and Practical Psychopharmacology

Skeletal and Dental Fractures Associated With Electroconvulsive Therapy

Recent data suggest the risk of skeletal or dental fracture with ECT may be as low as...